DLHC
DLH Holdings Corp.DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. The company offers defense and veterans' health solutions, including healthcare, technology, and logistics solutions to the VA, Defense Health Agency, Tele-medicine and Advanced Technology Research Center, Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. It also provides a range o
2-Year Price History
Quarterly Financials & Projections
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Est | 2028-Q2 | 64.0 | 6.4 | -- | -0.3 | -- | 4.8 | -0.2 | 20.9 | -- | -- | -- | -- | -- |
| Est | 2028-Q1 | 61.0 | 5.8 | -- | -0.9 | -- | -1.8 | -0.2 | 16.1 | -- | -- | -- | -- | -- |
| Est | 2027-Q4 | 62.0 | 6.2 | -- | -0.6 | -- | 5.6 | -0.2 | 17.9 | -- | -- | -- | -- | -- |
| Est | 2027-Q3 | 60.0 | 5.7 | -- | -0.9 | -- | 4.2 | -0.2 | 12.3 | -- | -- | -- | -- | -- |
| Est | 2027-Q2 | 58.0 | 5.2 | -- | -1.2 | -- | 3.5 | -0.2 | 8.1 | -- | -- | -- | -- | -- |
| Est | 2027-Q1 | 56.0 | 4.8 | -- | -1.7 | -- | -2.8 | -0.2 | 4.6 | -- | -- | -- | -- | -- |
| Est | 2026-Q4 | 57.0 | 5.1 | -- | -1.4 | -- | 4.6 | -0.1 | 7.4 | -- | -- | -- | -- | -- |
| Est | 2026-Q3 | 55.0 | 4.7 | -- | -1.7 | -- | 2.8 | -0.1 | 2.9 | -- | -- | -- | -- | -- |
| Act | 2026-Q2 | 59.3 | 4.3 | -0.1 | -2.5 | 3.8 | 3.8 | -0.0 | 0.1 | 145.6 | 14.4 | -0.1% | 1.4x | 9.8x |
| Act | 2026-Q1 | 68.9 | 5.3 | 1.4 | -1.3 | -4.8 | -4.8 | -0.0 | 0.3 | 149.8 | 14.4 | 2.9% | 1.6x | 8.2x |
| Act | 2025-Q4 | 81.2 | 6.2 | 2.3 | -0.9 | 10.7 | 10.7 | -0.0 | 0.1 | 145.0 | 14.4 | 4.6% | 1.8x | 7.1x |
| Act | 2025-Q3 | 83.3 | 7.7 | 3.8 | 0.3 | 9.6 | 9.4 | -0.2 | 0.2 | 155.9 | 14.5 | 7.2% | 2.1x | 5.8x |
| Act | 2025-Q2 | 89.2 | 9.0 | 5.1 | 0.9 | 14.5 | 15.1 | -0.6 | 0.2 | 162.7 | 14.5 | 8.8% | 2.3x | 7.2x |
| Act | 2025-Q1 | 90.8 | 9.5 | 5.6 | 1.1 | -11.5 | -12.1 | -0.6 | 0.5 | 178.3 | 14.6 | 9.1% | 2.3x | 7.9x |
| Act | 2024-Q4 | 96.4 | 10.3 | 6.4 | 2.3 | 12.4 | 12.2 | -0.2 | 0.3 | 164.8 | 14.4 | 11.7% | 2.5x | 7.9x |
| Act | 2024-Q3 | 100.7 | 9.7 | 5.8 | 1.1 | 4.6 | 4.5 | -0.2 | 0.4 | 177.3 | 14.7 | 9.2% | 2.3x | 10.8x |
| Act | 2024-Q2 | 101.0 | 9.8 | 5.9 | 1.8 | 5.2 | 4.9 | -0.3 | 0.2 | 182.3 | 15.0 | 10.2% | 2.3x | 11.6x |
| Act | 2024-Q1 | 97.9 | 10.4 | 6.8 | 2.2 | 5.1 | 4.9 | -0.2 | 0.1 | 186.4 | 14.8 | 11.5% | 2.2x | 10.1x |
| Act | 2023-Q4 | 101.5 | 3.9 | 0.2 | -2.6 | 16.0 | 16.0 | -0.0 | 0.2 | 191.7 | 13.9 | 0.3% | 0.8x | 10.9x |
| Act | 2023-Q3 | 102.2 | 10.8 | 7.1 | 1.7 | 8.1 | 8.0 | -0.1 | 0.5 | 208.1 | 14.5 | 10.3% | 2.2x | 10.8x |
| Act | 2023-Q2 | 99.4 | 9.9 | 6.0 | 0.8 | -1.1 | -1.2 | -0.1 | 0.1 | 216.7 | 14.6 | 8.4% | 2.1x | 12.0x |
| Act | 2023-Q1 | 72.7 | 6.1 | 3.9 | 1.6 | 8.0 | 7.6 | -0.4 | 1.4 | 216.1 | 14.3 | 5.1% | 3.3x | 11.4x |
| Act | 2022-Q4 | 67.2 | 6.5 | 4.7 | 3.4 | 6.0 | 5.4 | -0.6 | 0.2 | 39.1 | 14.3 | 19.7% | 13.5x | 6.3x |
| Act | 2022-Q3 | 66.4 | 8.8 | 7.1 | 4.9 | 10.1 | 9.9 | -0.2 | 1.1 | 46.0 | 14.2 | 26.0% | 17.2x | -- |
| Act | 2022-Q2 | 108.7 | 12.0 | 10.3 | 7.2 | 1.3 | 1.3 | -0.1 | 0.4 | 55.4 | 14.4 | 35.4% | 21.6x | -- |
| Act | 2022-Q1 | 152.8 | 13.1 | 11.2 | 7.8 | -16.2 | -16.2 | -0.0 | 4.2 | 61.2 | 14.3 | 39.8% | 19.4x | -- |
Multiples vs the company's own history — cheap or rich relative to itself? Historical fiscal years, then TTM, then forward projections (E). Forward rows hold today's price against projected earnings, so the multiple compresses if the company grows into it.
| Year | Price | Rev Gr | EBITDA % | EBITDA | EV/EBITDA | EV/FCF | P/E | P/S |
|---|---|---|---|---|---|---|---|---|
| 2022 | 11.87 | — | 10.2% | 40 | 5.1× | 549.5× | 7.1× | 0.4× |
| 2023 | 15.75 | -4.9% | 8.2% | 31 | 11.7× | 11.8× | 114.0× | 0.4× |
| 2024 | 8.03 | +5.3% | 10.1% | 40 | 7.4× | 11.2× | 17.8× | 0.3× |
| 2025 | 5.65 | -13.0% | 9.4% | 32 | 7.0× | 9.9× | 60.4× | 0.2× |
| TTM | 5.61 | -22.4% | 8.0% | 23 | 0.0× | 0.0× | 0.0× | 0.0× |
| 2027E | 5.61 | -19.4% | 0.1% | 0 | 0.0× | 0.0× | 0.0× | 0.0× |
EBITDA in reporting-currency $M. Historical multiples use year-end market cap (split-adjusted price history); TTM & forward years use today's.
AI Analysis
LLM Evaluations
DLH Holdings is a structurally impaired government services company that has lost its prime contractor position on key legacy programs, resulting in a 34% revenue decline with no near-term recovery catalyst. The company carries $132.7M in debt against a shrinking ~$230M revenue base, with interest coverage of just 1.4x and virtually zero cash on hand ($131K). While management is attempting a strategic pivot toward defense/cybersecurity, this requires winning new contracts in a highly competitive environment from a position of financial weakness. The $138M goodwill balance (50% of assets, 166% of market cap) is almost certainly overstated and a future impairment would devastate equity. Insiders are buying but this appears to be RSU vesting activity rather than open-market conviction. The covenant amendment in November 2024 signals the company was near default, and continued revenue erosion could trigger another covenant crisis. At 4.4x P/FCF the stock looks optically cheap, but the EV/FCF of 12x on declining FCF with high leverage makes this a value trap rather than a value opportunity.
Latest Earnings Call
Transcript Summary
DLH Holdings Corp. reported Q2 2026 revenue of $59.3 million, down from $89.2 million year-over-year, largely due to the transition of VA CMOP and Head Start contracts to small business set-asides. Despite the revenue decline, the company achieved a 9% adjusted EBITDA margin and reduced total debt to $132.7 million. Management highlighted a two-year sole-source extension with the NIH and emphasized a strategic pivot toward defense and intelligence markets, which are seeing significant budget increases. CEO Zachary Parker noted that while federal health spending may face cuts, the company’s investments in AI, cybersecurity, and digital transformation align with high-priority government initiatives. During the Q&A, the company confirmed that the VA CMOP transition would conclude by Memorial Day 2026 and expressed optimism about a renewed pipeline of RFPs following a period of budget uncertainty. DLH has completed its major cost-scaling actions and remains focused on deleveraging the balance sheet while pursuing high-value organic growth. The outlook remains cautious but positive as the company navigates a temporary contraction phase and prepares for a busier procurement environment in the second half of the fiscal year.
Valuation & Metrics
Market Stats
TTM Financial Snapshot
DCF Fair Value Estimate
Forward Outlook & Risk
Short Interest
Options
| Strike | Call Bid/Ask | Call OI | Put Bid/Ask | Put OI |
|---|---|---|---|---|
| $2.50 | $2.70/$3.50 | 0 | --/$0.50 | 0 |
| $5.00 | $0.35/$1.10 | 0 | --/$0.50 | 0 |
| $7.50 | --/$0.50 | 0 | $1.50/$2.30 | 0 |
| $10.00 | --/$0.50 | 0 | $4.00/$4.80 | 0 |
Forward Projections & Estimates
Employees
Institutional Ownership
Headline & net flow
In Q1 2026 so far (quarter still filing), institutions are roughly balanced — bought 2.3% of float, sold 1.5%.
Ownership composition
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC | $21.4M | $18.94 | +$0 | +$0 | +0.4% | $148M |
| Mink Brook Asset Management LLC | $15.6M | $6.89 | +$301K | +$7.2M | +0.9% | $179M |
| Minerva Advisors LLC | $6.5M | $8.48 | −$0 | +$551K | -1.5% | $155M |
| VANGUARD CAPITAL MANAGEMENT LLCPassive | $2.6M | $5.82 | +$2.6M | +$2.6M | — | $4.04T |
| DIMENSIONAL FUND ADVISORS LPPassive | $1.4M | $12.41 | −$7K | −$70K | -0.4% | $480.92B |
| RBF Capital, LLC | $1.3M | $5.84 | +$0 | +$1.3M | +0.1% | $2.03B |
| RENAISSANCE TECHNOLOGIES LLC | $1.1M | $8.49 | −$96K | −$400K | +1.2% | $63.91B |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $806K | $12.73 | +$2K | −$538K | +2.3% | $1.61T |
| North Star Investment Management Corp. | $786K | $5.82 | +$786K | +$786K | -0.4% | $1.65B |
| US BANCORP \DE\ | $667K | $5.65 | +$0 | +$667K | -0.1% | $82.36B |
| BlackRock, Inc.Passive | $420K | $8.83 | +$5K | −$2.4M | -0.2% | $5.69T |
| VANGUARD FIDUCIARY TRUST COPassive | $384K | $5.82 | +$384K | +$384K | — | $395.83B |
| STATE STREET CORPPassive | $347K | $10.49 | +$0 | −$307K | -0.2% | $2.89T |
| FIFTH THIRD BANCORP | $292K | $9.36 | +$0 | +$0 | -0.1% | $54.56B |
| CITADEL ADVISORS LLC | $286K | $8.69 | +$7K | +$64K | -0.4% | $138.22B |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $281K | $9.36 | −$12K | −$259K | -2.3% | $4.93B |
| MORGAN STANLEY | $263K | $7.14 | −$24K | −$192K | -0.3% | $1.65T |
| Proficio Capital Partners LLC | $223K | $5.67 | +$20K | +$223K | -0.5% | $1.87B |
| NORTHERN TRUST CORPPassive | $211K | $9.38 | +$0 | −$217K | -0.2% | $755.34B |
| Rothschild Wealth LLC | $170K | $5.65 | −$786K | +$170K | -6.3% | $1.10B |
Trading behavior
▸ Compare to holder-profile behavior (across all their stocks)
Biggest decreases this quarter
New buyers this quarter
Top-5 holders · 85.7%
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
Analyst Coverage
| Quarter | Revenue | EBITDA | Net Inc | EPS | EPS Range | # Analysts |
|---|---|---|---|---|---|---|
| 2024 Q2 | 103M | 10M | 2M | $0.14 | $0.14 – $0.14 | 1 |
| 2024 Q3 | 101M | 10M | 2M | $0.11 | $0.11 – $0.11 | 1 |
| 2024 Q4 | 97M | 9M | 1M | $0.07 | $0.07 – $0.07 | 1 |
| 2025 Q1 | 90M | 9M | 1M | $0.07 | $0.07 – $0.07 | 1 |
| 2025 Q2 | 83M | 8M | 0M | $0.02 | $0.02 – $0.02 | 1 |
| 2025 Q3 | 84M | 8M | 0M | $0.02 | $0.02 – $0.02 | 1 |
| 2025 Q4 | 70M | 7M | -1M | $-0.07 | $-0.07 – $-0.07 | 1 |
| 2026 Q1 | 58M | 6M | -2M | $-0.16 | $-0.16 – $-0.16 | 1 |
| 2026 Q2 | 50M | 5M | -2M | $-0.17 | $-0.17 – $-0.17 | 1 |
| 2026 Q3 | 50M | 5M | -2M | $-0.16 | $-0.16 – $-0.16 | 1 |
Corporate
Executive Compensation (2023-2025)
Insider Trading (last 12mo)
| Date | Side | Insider | Title | Shares | Price | Dollars | Owned $ |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 1,584 | $5.50 | $9K | $11.34M |
| 2026-05-20 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 120 | $5.50 | $660 | $11.33M |
| 2026-05-19 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 2,397 | $5.50 | $13K | $11.33M |
| 2026-05-18 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 5,304 | $5.50 | $29K | $11.32M |
| 2026-05-14 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 512 | $5.50 | $3K | $11.29M |
| 2026-05-13 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 68,547 | $5.50 | $377K | $11.29M |
| 2026-04-07 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 196 | $5.50 | $1K | $10.91M |
| 2026-02-19 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 8,048 | $5.50 | $44K | $10.91M |
| 2026-02-18 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 22,057 | $5.50 | $121K | $10.86M |
| 2026-02-17 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 2,642 | $5.50 | $15K | $10.74M |
| 2026-02-13 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 319 | $5.50 | $2K | $10.73M |
| 2026-02-12 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 13,577 | $5.50 | $75K | $10.73M |
| 2026-01-08 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 1,458 | $5.50 | $8K | $10.65M |
| 2026-01-07 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 3,569 | $5.50 | $20K | $10.64M |
| 2025-12-18 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 78 | $5.50 | $429 | $10.62M |
| 2025-12-17 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 44,208 | $5.50 | $243K | $10.62M |
| 2025-12-11 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 924 | $5.50 | $5K | $10.38M |
| 2025-10-20 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 202 | $5.50 | $1K | $10.37M |
| 2025-10-17 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 645 | $5.50 | $4K | $10.37M |
| 2025-10-16 | BUY | Mink Brook Asset Management LLC | 10 percent owner | 165 | $5.50 | $908 | $10.37M |
Order Flow (FINRA, ~3w lag)
Revenue Breakdown
Revenue Segments
| Fixed-Price Contract | $24.0M | NEW |
| Time-and-Materials Contract | $21.4M | NEW |
| Cost Reimbursable Contract | $14.0M | NEW |
Filing Risk Analysis
Filing Risk Scores
DLH Holdings: A House of Intangibles Built on a Foundation of Vanishing Cash
Counter-Thesis
Counter-Thesis & Recent News
DLH Holdings reported a severe 33.5% year-over-year revenue decline for fiscal Q2 2026 (ended March 31, 2026), with sales dropping to $59.3 million from $89.2 million. The company swung to a net loss of $2.5 million ($(0.17) per share), significantly missing analyst estimates of a $(0.08) loss. This follows a Q1 2026 miss where EPS was -$0.09 versus a forecasted +$0.07. Management cited the mandatory transition of high-value legacy contracts to small-business competitors as the primary cause (Sources: Stock Titan, Investing.com, MarketBeat).
The core bear case centers on a structural 'reset' in the company's scale. DLHC is losing its status as a prime contractor on major legacy programs, specifically the VA’s Consolidated Mail Outpatient Pharmacy (CMOP) and the Office of Head Start (OHS) contracts, which are being unbundled and set aside for small businesses. The Head Start loss alone stripped approximately $40 million in annual revenue. With total backlog contracting by 14% to $442.4 million and funded backlog dropping to $75 million, the revenue pipeline is visibly shrinking, leaving the company with a smaller, less profitable footprint (Sources: Noble Capital Markets, Stock Titan, SEC Filings).
Financial health metrics have deteriorated, with the company reporting a negative profit margin (-0.33%) and negative return on equity (-0.95%) in early 2026. A significant red flag is the high debt load of $132.7 million relative to a shrinking revenue base and market cap (~$85M), which increases leverage risks during this 'transition year.' Additionally, a whistleblower lawsuit (Morrell v. DLH Holdings Corp.) involving allegations of misallocated fringe benefits and non-compliance with bank reporting covenants reached an appellate conclusion in late 2024, highlighting past internal control concerns (Sources: MarketBeat, U.S. Dept of Labor).
The primary threat is regulatory/structural: the federal government's increasing mandate to award contracts to Service-Disabled Veteran-Owned Small Businesses (SDVOSB). As DLH has matured beyond small-business status, it is being systematically pushed out of legacy contracts by smaller, set-aside-eligible firms. Competitors in the federal health IT and cybersecurity space also threaten their pivot toward 'Technology Powered Solutions' (TPS), where they face stiff competition from better-capitalized mid-tier and large-scale integrators (Sources: TipRanks, Matrix BCG).
Sentiment among major customers like the VA and HHS has shifted toward de-risking and diversification through unbundling. While DLHC maintains some sole-source extensions (like the NIH clinical research contract), the overall trend shows key agencies prioritizing small-business socioeconomic goals over long-standing prime relationships with DLH. This shift has led to a depletion of 'past performance' advantages in their most lucrative legacy segments (Sources: Matrix BCG, Motley Fool Transcript).
Full Earnings Call Transcript
Full Earnings Call Transcript — Q2 • 2026-05-07
Operator: Good day, and welcome to the DLH Holdings Corp. Fiscal 2026 Second Quarter Earnings Conference Call. All participants will be in listen-only mode. Please note this event is being recorded. I would now like to turn the conference over to Chris Witty, Investor Relations Advisor. Please go ahead, Chris. Chris Witty: Thank you, and good morning, everyone. On the call with me today is Zachary C. Parker, President and Chief Executive Officer, and Kathryn M. Johnbull, Chief Financial Officer. The company's earnings release and PowerPoint presentation are available on our website under the Investor page. I would now like to provide a brief Safe Harbor statement, which is also shown on Slide 3 of the presentation. This call may include forward-looking statements that relate to the company's outlook for fiscal 2026 and beyond. These statements are subject to various risks and uncertainties and could cause actual results and events to differ materially from such statements. Please refer to the risk factors contained in the company's Annual Report on Form 10-K and in our other filings with the Securities and Exchange Commission. We do not undertake any duty to update any forward-looking statements. On today's call, we will be referencing both GAAP and non-GAAP financial measures. A reconciliation of our non-GAAP results to our reported GAAP results is included in our earnings release and in the investor presentation on DLH Holdings Corp.'s website. President and CEO, Zachary C. Parker, will speak next, followed by CFO, Kathryn M. Johnbull, after which we will open it up for questions. With that, I would now like to turn the call over to Zachary C. Parker. Please go ahead, Zachary C. Parker. Zachary C. Parker: Thank you, Chris Witty, and good morning, everyone. Welcome to our second quarter conference call. I am pleased for the opportunity to report our financial results and provide color regarding the current environment and our outlook. As I begin, I would like to recognize the performance of our highly skilled workforce. Our people are our number one asset as a company, and we lean on the passion, creativity, and expertise of our staff in order to succeed. This past quarter, you once again demonstrated the innovative thinking required to support our customers' critical missions and delivered excellence across the way. We continue to thank everyone at DLH Holdings Corp. for this execution. Now turning to Slide 4, I will provide an overview of the federal marketplace achievements and financial performance. The fiscal 2026 budget cycle is now complete, and the 2027 outlook is coming into full focus. We believe that the current federal funding environment is favorable to DLH Holdings Corp. Clients across our markets have increased funding capacity and improved budget visibility, allowing for a steadily improving procurement environment. Key federal health agencies received FY 2026 funding increases compared to FY 2025 levels, reversing in part the previously proposed funding reductions outlined by the President's request for fiscal 2026. Agencies in the defense and intelligence market have received significant budget increases that align particularly well with our capabilities. These are supported on both sides of the aisle, and we expect this to be a healthy profile for us in the years to come. We believe that the improved clarity and stability which has emerged in recent months meaningfully expands the company's addressable market and supports the company's strategic organic growth initiatives. Last year, and throughout the shutdown in our fiscal Q1, budget uncertainty and large reductions to federal agency contracting departments significantly slowed procurement activity across the government. As such, numerous key deals and strategic large procurements that we were expecting in 2025 are just now coming up for bid. We are encouraged by the increase in bidding activities and are experiencing a busy second half of the fiscal year responding to procurement requests. We expect certain award decisions over the coming months, subject to customer timelines and procurement processes. DLH Holdings Corp. continues to maintain a healthy pipeline of opportunities which will leverage our world-class workforce, our advanced capabilities, and our recently developed commercial technology differentiators to elevate our win probabilities in this pipeline. Notably, the President's recently released fiscal 2027 budget request calls for historic spending increases in the defense and intelligence sector. The administration proposes that this investment be partially offset by unspecified reductions in federal health spending. As always, the President's budget request is an initial step in the multi-phase federal budget cycle. We will remain engaged with the Hill, our customers, and influential industry groups as this process advances. Additionally, the current administration has taken several actions intended to simplify contracting and to accelerate the time required to complete transactions. We find this is very healthy for our industry. In addition to nontraditional contract arrangements that we discussed at our recent shareholder meeting, there have been executive orders to streamline the regulatory environment in contracting and to rebalance the risk-reward trade-off, moving away from some cost-reimbursement contracts to fixed-price arrangements with performance metrics. The changes align very well with DLH Holdings Corp.'s strategy and our heritage. We welcome this needed shift by our government. Our defense and intelligence customers continue to prioritize prototyping, rapid delivery, cost efficiency, digital modernization, and the integration of advanced technologies, particularly as they relate to C4ISR systems. These align very well with our DLH Holdings Corp. Cyclone and DLH Holdings Corp. Nexus Labs digital sandbox investments that are cloud-secure. In parallel, federal health agencies remain focused on interoperability, cybersecurity including zero trust architectures, cloud migration, and AI adoption. Collectively, these priorities position DLH Holdings Corp. very strongly to grow organically from these initiatives. It is always gratifying when DLH Holdings Corp. innovation and performance excellence are acknowledged by our industry. In recent months, DLH Holdings Corp.-supported projects in automation, artificial intelligence, scientific research, data science, and information technology were recognized by customer and industry organizations for outstanding program performance and significant technology achievements. We are proud of these accomplishments, as they illustrate the thought leadership, ingenuity, and passion of our employees in advancing the missions of our customers. While revenue was down year over year, largely due to the previously discussed program transitions to small business set-aside contracts—these include the VA CMOP and Head Start—we remain committed to maximizing shareholder value. Through strong project management, delivered margins, and implemented cost-scaling initiatives, we delivered adjusted EBITDA margin of 9%. As Kathryn M. Johnbull will discuss in more detail shortly, we continue to delever our commitment to the balance sheet. Total debt was reduced to $132.7 million, aligned with our debt reduction plans for fiscal 2026. In late-breaking news, we were awarded a two-year sole-source extension of one of our contracts to provide world-class clinical research support services to the National Institutes of Health. We truly appreciate the opportunity to continue this tremendous support in this critical public health mission that has been a primary focus area for DLH Holdings Corp. for decades. Overall, we remain well positioned to succeed over the coming years and are excited to vie for the high-value organic growth opportunities that our company was assembled to compete for. Our differentiated suite of data science and AI/ML technology applications, our outstanding capabilities, and our workforce alignment exceptionally well position us for work within our three strategic pillars: science, research and development; digital transformation and cybersecurity; and systems engineering and integration. As government acquisition strategies evolve, we remain prepared and proactive, leveraging speed, innovation, and agility to compete on multiple fronts in an accelerated acquisition landscape. With that, I would now like to turn the call over to our Chief Financial Officer, Kathryn M. Johnbull. Kathryn M. Johnbull? Kathryn M. Johnbull: Thank you, Zachary C. Parker, and good morning, everyone. Thanks for joining as we report on our second quarter results for fiscal 2026. Turning to Slide 6, I would like to first provide a high-level overview of some key financial metrics for the three months ended 03/31/2026. We reported revenue of $59.3 million in the second quarter, versus $89.2 million in the prior-year period, reflecting contributions from expansion on existing contracts offset by the impact of conversion of certain programs to small business set-aside contracts, as discussed in the past, and certain government efficiency initiatives. In total, the revenue contraction was mostly due to small business set-aside initiatives, primarily from CMOP and Head Start, with approximately a $24 million increase in the quarter-over-quarter results [inaudible]. The remaining change was due to year-over-year contract completions and government efficiency initiatives. We reported adjusted EBITDA of $5.3 million for the quarter, compared to $9.4 million in the prior-year period, with the decrease primarily driven by the change in revenue volumes. Adjusted EBITDA margin was 9% for the quarter, adjusting for the timing and incremental cost impact of our cost-scaling initiatives implemented in the second quarter. From a free cash flow standpoint, we generated approximately $3.8 million during the quarter. In comparison to the prior-year period, the prior year reflects the results of significant working capital build stemming from the transition of a CMOP location that restricted cash collections early in fiscal 2025. Now turning to Slide 7, I will wrap up with a summary of our debt reduction efforts, which remain a key focus area for DLH Holdings Corp. Debt reduced during the quarter to $132.7 million, a reduction from $136.6 million at the end of the previous quarter. This marks the resumption of our deleveraging trend after the typical seasonal uptick we experienced in the first quarter. We expect to convert approximately 50% to 55% of EBITDA generated during fiscal 2026 to reduce debt by year end. We remain well ahead of our mandatory repayment schedule and in full compliance with all financial covenants. With that, I would now like to turn the call over to our operator to open up for questions. Operator: We will now begin the question and answer session. If you are using a speakerphone, our first question comes from Joseph Gomes with NOBLE Capital. Joseph Gomes: Good morning. I just want to start out on the VA CMOP. Do we have anything left there? How much longer do you think that is going to run through? I know we were hoping it would end in this fiscal third quarter of this year, but maybe a little update on where we stand on that. Zachary C. Parker: Yes, I think we are still on plan with regard to that reduction. You know, the VA and our team have been working collaboratively towards standing down the final couple operations. Kathryn M. Johnbull, do you have any greater specificity for that? Kathryn M. Johnbull: Sure. Yes, our expectation is that we will wrap up the transition of those contracts just before Memorial Day. Joseph Gomes: Okay. Get that behind us. Kathryn M. Johnbull: Yes, sir. Zachary C. Parker: Yes, it obviously served us well. We remain committed, Joseph Gomes, to supporting our nation's veterans. We have still got irons in the fire for transitioning to different types of work for the VA. But once the VA changed that acquisition process, not only to small business set-aside, but changed it from being a solutions- and tech-derived execution to just butts-in-seats, we withdrew all of our joint venture bids and approached it accordingly. So it is bittersweet. As you know, we had a couple of decades of support in that arena. But we wish the small business community well. Joseph Gomes: Right, exactly. Agreed. And then, Zachary C. Parker, you talked about how there have been multiple delayed procurements. There are some going through the pipeline now, just now coming up for bids. You are hoping to hear something here in the next couple of months. I guess the concern is, obviously, every September 30th we go into a threatened government shutdown, a continuing resolution, all that, which then seems to always delay contracts. What is your comfort level of actually seeing some of these contracts be awarded in a timely manner versus getting caught back up in the whole continuing resolution issue? And then if you might be able to provide us a little more color on the nice late-breaking news of the new award that you received. Zachary C. Parker: You bet, Joseph Gomes. First of all, I will cover what we see in the market, and I will ask Kathryn M. Johnbull to address the extensions. We are always very mindful of what the headwinds could be, as we have come to know continuing resolutions and shutdown risk quite well over the recent years and certainly with this administration. We are also encouraged by some multiyear funding initiatives that have gone forward. They have already been approved, and we anticipate continuing to move forward in selected agencies. We particularly still find good strength and support on both sides for defense and intelligence budgets as well as critical health care programs, so we are pretty comfortable in that arena. More importantly, in the last quarter we have seen multiple RFPs that we have been signaling were coming, and fortunately, these have gotten under the wire before the usual September crisis. I think that was also attributed to some of the budget visibility once they got the budget passed. Customers have had pent-up demands for moving along on some of these procurements. We think that the fact that we have had three or four of the more material ones come through already, we have submitted bids, and we are hopeful that the decision process will also move forward in the coming quarter. Often for very material bids, you may see a protest or something of that nature that might delay the actual award and start of work. But we believe that we have some where we are very well positioned and that we should have decisions by this fiscal year. With regard to the contract extensions, Kathryn M. Johnbull, over to you. Kathryn M. Johnbull: Sure. Yes, as we mentioned, it is the continuation of a key contract we have been working in support of the NIH for a number of decades. It would have gone through a normal recompete cycle at the completion of its 10-year period of performance here shortly, but the NIH has decided to, or made the case to, extend it under a sole-source bridge for two years. So anytime an important part of your portfolio gets an extension and gives you additional revenue visibility, that is always very welcomed. And that is work that really reflects, as Zachary C. Parker mentioned earlier, just as we value a strong presence and continue to have interest in veterans’ health, public health is a key dimension of our portfolio and market-facing strategy for addressing every aspect of federal health care delivery. This part of our portfolio of contracts in that public health sector is very critical to us. So we are pleased and honored to be able to continue to provide that support and to get the additional revenue visibility in the short run. Joseph Gomes: Okay. Thank you for that color. And then on the cost scaling or the right-sizing, are we where we need to be for the current or the expected near-term revenue production, or do you think there might be more cost scaling that needs to occur here? Kathryn M. Johnbull: I think we have done the significant actions. We always have some strategies we are working through, and those would continue to be, as leases come due for example, continuing to evaluate our footprint in our real estate—those kinds of activities. So we continue to evaluate and assure that our cost structure remains competitive and allows our rates to stay competitive for bidding on new work. But we think that we have accomplished the material reductions that are necessary to right-size the business. Joseph Gomes: Okay, great. Thanks. I will get back in queue. Zachary C. Parker: You bet. Thank you, Joseph Gomes. Thanks, Joseph Gomes. Hearing none, do we want to reopen it for Joseph Gomes? Operator: He is not back in the queue. Joseph Gomes, if you need to requeue. Zachary C. Parker: Just give Joseph Gomes a second as he gets himself back in the queue. Operator: We will move forward. Alrighty. So with that— Zachary C. Parker: I would like to thank everyone for your participation throughout this call. Joseph Gomes, anything else? Joseph Gomes: Yes. Maybe a little more. Zachary C. Parker, you talked about some of the potential reprioritizing of federal health spending. Given what we have seen here in the past couple of years, it has been a challenging time for DLH Holdings Corp. with losing the CMOP business and Head Start, and to potentially see reprioritizing federal health spending just throws up additional challenges for the company. Maybe give us a little more of your thoughts and color on how you are going to go about addressing this. Zachary C. Parker: You bet. Great question again, Joseph Gomes. I think the best way we characterize it is, as you well know, we communicated and tried to be very transparent regarding what was largely fueled by the Biden administration's commitment to move not only the VA but a number of other agencies’ contracts to small business. We anticipated that erosion—it started in 2024 and certainly matured in 2025—and as you indicated earlier, we expect to have the final pieces of the headline set-aside for us, which was VA CMOP, running out this year. But we are also well positioned, and we are very optimistic that the RFPs and solicitations that had been earmarked for 2024, aligned with our establishment of our differentiators in data science and data analytics, were going to be fueled by RFPs in 2025. Unfortunately, as we indicated earlier, the overwhelming majority of those basically stalled. So we had a relatively flat bid cycle for the major new business deals that are just now coming around. A few of those have evolved from the government deciding to move toward some grants. The DOJ certainly impacted a lot of our clients where they did not have the acquisition officials to issue those RFPs. They have begun to stabilize that over the course of the last six months, and again we are starting to see both in the defense and intel side and in the public health arena those solicitations come back. So we have got a few we are anticipating in the next few months. We have a pretty healthy revenue potential for some that were recently submitted, so we are optimistic that the trend will continue. We are not expecting to have a series of major DOJ program budget cuts followed by historical shutdowns in the coming months. And the global challenges, including the war in the Gulf, are going to keep a strong commitment of funding and rapid development initiatives for the defense and defense health arena as well. So right now we do see good optimism that the flatness in terms of opportunities for us to compete in 2025 is starting to break, and that is good for us. What we thought was going to be a pretty quick V-curve turned out to become a little more of a bathtub, but we are starting to see the opportunities hit now and certainly feel that we will be able to compete favorably for our share. Joseph Gomes: Thanks for that color, Zachary C. Parker. Much appreciated, and I am looking forward to starting to see some wins be put up on the board here after, as you said, a challenging period—nothing to really do with you guys, it is the government itself—but it would be nice to start to see the engine start back up again and be moving strongly going forward. Zachary C. Parker: We absolutely cannot wait. Yes, 100%. Kathryn M. Johnbull: Yes. Operator: This concludes our question and answer session. I would like to turn the conference back over to Zachary C. Parker for any closing remarks. Zachary C. Parker: Well, again, I want to thank you all for your interest in DLH Holdings Corp. We remain committed to driving shareholder value. We are looking forward to chatting with you in the coming quarters, and we ask everyone to have a blessed day. Joseph Gomes: And we will talk again soon. Zachary C. Parker: Bye for now. Operator: The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.